GLIAMED INC has a total of 21 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PROFECTUS BIOSCIENCES INC, REXAHN CORP and FUND CIENCIA PARA LA VIDA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Microorganisms | |
#5 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Hamilton Gregory S | 10 |
#2 | Weinstein David | 8 |
#3 | Li Jia-He | 4 |
#4 | Wu Yong-Qian | 3 |
#5 | Weinstein David E | 3 |
#6 | Norman Mark H | 2 |
#7 | Steiner Joseph | 2 |
#8 | Steiner Joseph P | 1 |
#9 | Huang Wei | 1 |
Publication | Filing date | Title |
---|---|---|
US2010317711A1 | Stem-like cells and method for reprogramming adult mammalian somatic cells | |
CA2709566A1 | Stem-like cells and method for reprogramming adult mammalian somatic cells | |
EP1998767A2 | Method for promoting composite tissue regeneration and uses thereof | |
EP1983833A2 | Method for promoting myocardial regeneration and uses thereof | |
US7189746B2 | Methods for promoting wound healing | |
US7253169B2 | Aza compounds, pharmaceutical compositions and methods of use | |
CN101245043A | Aza-heterocyclic compounds used to treat neurological disorders and hair loss | |
EP1842845A1 | Aza-heterocyclic compounds used to treat neurological disorders and hair loss | |
CA2602798A1 | Heterocyclic thioesters and ketones |